SHPT, Hyperphosphatemia Independently Linked With CKD Progression
Investigators ruled out hyperphosphatemia and SHPT as confounders in each other’s association with CKD outcomes.
Secondary Hyperparathyroidism
Study: Etelcalcetide Can Be Used Safely in Diabetic Nephropathy
Etelcalcetide use in patients with diabetic nephropathy might protect against development of adynamic bone disease, according to investigators.
Non-Calcium Phosphate Binder May Not Further Reduce Cardiovascular Events
Trial investigated lanthanum carbonate, which has been used worldwide to treat hyperphosphatemia and has been reported to delay vascular calcification.
Calciphylaxis Prevention and Treatment Strategies
Calciphylaxis treatment should include a multimodal approach with a focus on supportive care, infection prevention, pain management, and wound healing.
Results Mixed for Vitamin D Supplementation in SHPT
Gaps in the evidence-base for the management of vitamin D status in relation to CKD-MBD are hindering the formulation of comprehensive guidelines, according to investigators.
SHPT Management Found to Vary by Specialty
Unlike endocrinologists and surgeons, nephrologists tended to treat patients with calcimimetics rather than subtotal parathyroidectomy.
Investigators Identify Predictors of Post-Parathyroidectomy Hypocalcemia
In a large, single-center study, severe hypocalcemia developed in 1 in 4 patients who underwent total parathyroidectomy without autotransplantation.
Parathyroidectomy for Secondary Hyperparathyroidism Declining in the US
Despite a downtrend, Black patients underwent PTx at a 1.8-fold higher rate than White and Hispanic patients.
Adding Cinacalcet Shown Not to Slow Vascular Calcification in Hemodialysis
Overall control of hyperparathyroidism and hyperphosphatemia appeared to be associated with a reduction in left ventricular mass, however.
Study IDs Most Effective Strategies to Reduce Fibroblast Growth Factor 23
Circulating FGF23 starts to rise in early stage CKD before the development of other abnormalities such as high parathyroid and phosphate levels and low calcium and 1,25(OH)2D levels.
- Loading...
Loading...
Next post in Secondary Hyperparathyroidism
Loading... 
Loading...